Evidence map›Paper›PMID 38472981›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Clinical Indicators of Bone Deterioration in Alcoholic Liver Cirrhosis and Chronic Alcohol Abuse: Looking beyond Bone Fracture Occurrence.

Milos Stulic, Jelena Jadzic, Natasa Dostanic, Milica Zivkovic, Tihomir Stojkovic, Jelena Aleksic, Stefan Stojkovic, Milica Stojkovic Lalosevic, Marko Vojnovic, Zeljko Vlaisavljevic and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. The Liver-Bone Axis in Steatotic Liver Disease.Calcified tissue international · 2026
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Milos StulicClinic for Gastroenterohepatology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-9554-2106
Jelena JadzicCenter of Bone Biology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-3124-1400
Natasa DostanicSpecial Hospital for Addiction Diseases "Drajzerova", 11000 Belgrade, Serbia.
Milica ZivkovicInstitute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Tihomir StojkovicInstitute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-2400-6066
Jelena AleksicInstitute for Health Protection of Workers of Serbian Railways, 11000 Belgrade, Serbia.
Stefan StojkovicClinic for Gastroenterohepatology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-2256-7513
Milica Stojkovic LalosevicClinic for Gastroenterohepatology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0003-4836-4439
Marko VojnovicClinic for Gastroenterohepatology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Zeljko VlaisavljevicClinic for Gastroenterohepatology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-8050-4705
Jelena Martinov NestorovClinic for Gastroenterohepatology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Tatjana NikolićInstitute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-2185-7551
Violeta Culafic VojinovicEuromedik Hospital, 11000 Belgrade, Serbia.
Djordje CulaficClinic for Gastroenterohepatology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Danijela DjonicCenter of Bone Biology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
University of Belgrade · RSEuromedik · RS

Funding

Wellcome Trust 200110
6 · The paper itself

Abstract

Although previous studies indicated that chronic alcohol abuse (CAA) and alcoholic liver cirrhosis (ALC) are associated with increased bone fragility, understanding bone fragility determinants is still modest in these individuals. We used a comprehensive individualized clinical fracture risk assessment approach (vertebral osteodensitometry, femoral osteodensitometry and geometry, and serum bone turnover biomarkers) to compare adult male patients with ALC who have not previously had femoral or vertebral fractures (

Indexed as

alcoholic liver cirrhosisbone turnover biomarkerschronic alcohol abusedual-energy x-ray absorptiometry (DXA)FRAXhip structure analysismenosteoporosistrabecular bone score

Identifiers

PMID38472981
PMCPMC10930699
OpenAlexW4392238226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.